Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Ball Corporation delivered mixed results for the previous quarter, with revenues below analyst expectations but on-par earnings.</li>
<li>The year 2023 presented challenges for Ball Corporation, as comparable diluted earnings per share declined to $0.61 from $0.82 in 2022.</li>
<li>Net comparable earnings also decreased in the second quarter, driven by higher interest expenses, the impact of the Russian business sale in 2022, lower volumes, and increased corporate costs.</li>
</ul>


Ball Corporation delivered mixed results for the previous quarter, with revenues below analyst expectations but on-par earnings.
The year 2023 presented challenges for Ball Corporation, as comparable diluted earnings per share declined to $0.61 from $0.82 in 2022.
Net comparable earnings also decreased in the second quarter, driven by higher interest expenses, the impact of the Russian business sale in 2022, lower volumes, and increased corporate costs.


Ball Corporation: The Silver Lining in North America's Inflation Recovery! - Major Drivers

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/pact-group-holdings-ltd" target="_blank" data-smartkarma-citation="entities:692:1" rel="noopener">Pact Group Holdings (PGH AU)</a> has disclosed an unconditional takeover proposal from Raphael Geminder at A$0.68 per share, a 0.7% premium to the undisturbed price (12 September).</li>
<li>Mr. Geminder's justification for a little-to-no premium offer is based on the premise that minorities are clambering for a liquidity event to exit a no-hope situation. </li>
<li>The offer price is unattractive on any reasonable metric. A successful privatisation would require a bump. The shares closed 6.6% higher than the offer. </li>
</ul>



Pact Group Holdings (PGH AU) has disclosed an unconditional takeover proposal from Raphael Geminder at A$0.68 per share, a 0.7% premium to the undisturbed price (12 September).
Mr. Geminder's justification for a little-to-no premium offer is based on the premise that minorities are clambering for a liquidity event to exit a no-hope situation. 
The offer price is unattractive on any reasonable metric. A successful privatisation would require a bump. The shares closed 6.6% higher than the offer. 


Pact Group (PGH AU): Raphael Geminder’s Opportunistic Proposal

Equity Capital Markets

<ul>
<li>Amid tough year-over-year comparisons, largely driven by business divestments, Ball Corporation delivered a mixed set of results for the previous quarter with revenues well below analyst expectations but managed an earnings beat.</li>
<li>The company's aluminum beverage, as well as aerosol shipments, were in line with the regional expectations of the management.</li>
<li>However, the sales of the quarter decreased because of the sale of the company's Russian business, lower volumes, currency translation, and pass-through of lower aluminum prices.</li>
</ul>


Amid tough year-over-year comparisons, largely driven by business divestments, Ball Corporation delivered a mixed set of results for the previous quarter with revenues well below analyst expectations but managed an earnings beat.
The company's aluminum beverage, as well as aerosol shipments, were in line with the regional expectations of the management.
However, the sales of the quarter decreased because of the sale of the company's Russian business, lower volumes, currency translation, and pass-through of lower aluminum prices.


Ball Corporation: What Is Its Biggest Competitive Advantage? – Key Drivers

<ul><li>Ball's performance in the quarter was extremely disappointing and the company missed out on meeting Wall Street expectations with respect to revenues as well as earnings.</li><li>The company did see a decent performance in EMEA aerospace and aerosol operations, especially in its newly constructed facilities in EMEA.</li><li>The management believes that Ball's aerospace and aerosol segments are having ongoing success and will complement the activities of its global beverage operations.</li></ul>

Ball's performance in the quarter was extremely disappointing and the company missed out on meeting Wall Street expectations with respect to revenues as well as earnings.The company did see a decent performance in EMEA aerospace and aerosol operations, especially in its newly constructed facilities in EMEA.The management believes that Ball's aerospace and aerosol segments are having ongoing success and will complement the activities of its global beverage operations.

Ball Corporation: Details of Product Offerings & Key Drivers

Greatview Aseptic Packaging / Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/shandong-xinjufeng-technology-packaging-co-ltd" target="_blank" data-smartkarma-citation="entities:36744:1" rel="noopener">Shandong Xinjufeng Technology Packaging (301296 CH)</a> agreed to acquire <a href="https://www.smartkarma.com/entities/jardine-matheson-holdings-ltd" target="_blank" data-smartkarma-citation="entities:19718:1" rel="noopener">Jardine Matheson Holdings (JM SP)</a>’s 28.22% stake in <a href="https://www.smartkarma.com/entities/greatview-aseptic-packaging" target="_blank" data-smartkarma-citation="entities:10802:1" rel="noopener">Greatview Aseptic Packaging (468 HK)</a> at HK$2.65 per share.</li>
<li>Post-Completion, Xinjufeng will be the largest shareholder. As Xinjufeng’s shareholding will remain below the 30% voting threshold, the transaction will NOT result in a mandatory general offer. </li>
<li>The transaction price, which is a 22.7% premium to the last close, highlights Greatview’s value. Greatview’s forward P/E multiple is undemanding in comparison to peer P/E multiples.</li>
</ul>



Shandong Xinjufeng Technology Packaging (301296 CH) agreed to acquire Jardine Matheson Holdings (JM SP)’s 28.22% stake in Greatview Aseptic Packaging (468 HK) at HK$2.65 per share.
Post-Completion, Xinjufeng will be the largest shareholder. As Xinjufeng’s shareholding will remain below the 30% voting threshold, the transaction will NOT result in a mandatory general offer. 
The transaction price, which is a 22.7% premium to the last close, highlights Greatview’s value. Greatview’s forward P/E multiple is undemanding in comparison to peer P/E multiples.


Greatview Aseptic (468 HK): Xinjufeng Technology Acquires Jardine Matheson’s Stake

United States

Ball Corporation provides metal packaging for beverages, foods, and household products. The Company also supplies aerospace and other technologies and services to commercial and governmental customers. Ball serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ball (BALL US)

Ball Corporation: The Silver Lining in North America's Inflation Recovery! - Major Drivers

Ball Corporation delivered mixed results for the previous quarter, with revenues below analyst expectations but on-par earnings. The year 2023...

Baptista Research

Pact Group (PGH AU): Raphael Geminder’s Opportunistic Proposal

The offer price is unattractive on any reasonable metric. A successful privatisation would require a bump. The shares closed 6.6% higher than the...

Arun George

Ball Corporation: What Is Its Biggest Competitive Advantage? – Key Drivers

Amid tough year-over-year comparisons, largely driven by business divestments, Ball Corporation delivered a mixed set of results for the previous...

Baptista Research

Ball Corporation: Details of Product Offerings & Key Drivers

Ball's performance in the quarter was extremely disappointing and the company missed out on meeting Wall Street expectations with respect to...

Baptista Research

Greatview Aseptic (468 HK): Xinjufeng Technology Acquires Jardine Matheson’s Stake

The transaction price, which is a 22.7% premium to the last close, highlights Greatview’s value. Greatview’s forward P/E multiple is undemanding in...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)